Axsome Therapeutics is trading at $231.00 (-4.15%) in after-hours trading following a session with no confirmed company-specific news to account for the move.
- The price action may reflect thin extended-hours liquidity rather than a fresh fundamental catalyst.
- Broader market sentiment was mixed, characterized by Nasdaq weakness and a tech-led selloff, though no direct ties to the stock were identified.